JP7507897B2 - 生産効率を向上させる線毛無し大腸菌の構築及び使用 - Google Patents
生産効率を向上させる線毛無し大腸菌の構築及び使用 Download PDFInfo
- Publication number
- JP7507897B2 JP7507897B2 JP2022575251A JP2022575251A JP7507897B2 JP 7507897 B2 JP7507897 B2 JP 7507897B2 JP 2022575251 A JP2022575251 A JP 2022575251A JP 2022575251 A JP2022575251 A JP 2022575251A JP 7507897 B2 JP7507897 B2 JP 7507897B2
- Authority
- JP
- Japan
- Prior art keywords
- coli
- fermentation
- recombinant
- wqm026
- pbsk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000588724 Escherichia coli Species 0.000 title claims description 54
- 238000004519 manufacturing process Methods 0.000 title claims description 10
- 238000010276 construction Methods 0.000 title description 6
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 54
- 108090000623 proteins and genes Proteins 0.000 claims description 37
- 230000015572 biosynthetic process Effects 0.000 claims description 33
- 238000003786 synthesis reaction Methods 0.000 claims description 29
- 239000004473 Threonine Substances 0.000 claims description 28
- 229960002898 threonine Drugs 0.000 claims description 28
- 238000000855 fermentation Methods 0.000 claims description 27
- 230000004151 fermentation Effects 0.000 claims description 27
- 239000013612 plasmid Substances 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 20
- 230000012010 growth Effects 0.000 claims description 17
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 16
- 229940024606 amino acid Drugs 0.000 claims description 15
- 150000001413 amino acids Chemical class 0.000 claims description 15
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 9
- 230000002950 deficient Effects 0.000 claims description 9
- 239000008103 glucose Substances 0.000 claims description 9
- 241000660147 Escherichia coli str. K-12 substr. MG1655 Species 0.000 claims description 8
- 241001076388 Fimbria Species 0.000 claims description 8
- 239000007836 KH2PO4 Substances 0.000 claims description 8
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 8
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 8
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 claims description 8
- 239000011780 sodium chloride Substances 0.000 claims description 8
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 6
- 239000001110 calcium chloride Substances 0.000 claims description 6
- 235000011148 calcium chloride Nutrition 0.000 claims description 6
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 6
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 6
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 6
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 5
- 235000019270 ammonium chloride Nutrition 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 239000002207 metabolite Substances 0.000 claims description 4
- 101150054290 ydeR gene Proteins 0.000 claims description 4
- 101100497599 Bacillus subtilis (strain 168) cwlJ gene Proteins 0.000 claims description 3
- 101100069807 Bacillus subtilis (strain 168) gudD gene Proteins 0.000 claims description 3
- 101100520858 Bacillus subtilis (strain 168) phoD gene Proteins 0.000 claims description 3
- 101100536412 Bacillus subtilis (strain 168) tatC1 gene Proteins 0.000 claims description 3
- 101100212944 Bacillus subtilis (strain 168) ycbR gene Proteins 0.000 claims description 3
- 101100446530 Bordetella pertussis (strain Tohama I / ATCC BAA-589 / NCTC 13251) fhaE gene Proteins 0.000 claims description 3
- 101100171644 Escherichia coli (strain K12) ecpB gene Proteins 0.000 claims description 3
- 101100173675 Escherichia coli (strain K12) fimG gene Proteins 0.000 claims description 3
- 101100505031 Escherichia coli (strain K12) gltF gene Proteins 0.000 claims description 3
- 101100042411 Escherichia coli (strain K12) sfmC gene Proteins 0.000 claims description 3
- 101100042414 Escherichia coli (strain K12) sfmF gene Proteins 0.000 claims description 3
- 101100042415 Escherichia coli (strain K12) sfmH gene Proteins 0.000 claims description 3
- 101100159448 Escherichia coli (strain K12) ycbF gene Proteins 0.000 claims description 3
- 101100212947 Escherichia coli (strain K12) ycbV gene Proteins 0.000 claims description 3
- 101150046913 ecpA gene Proteins 0.000 claims description 3
- 101150055903 ecpC gene Proteins 0.000 claims description 3
- 101150114495 ecpD gene Proteins 0.000 claims description 3
- 101150065299 ecpE gene Proteins 0.000 claims description 3
- 101150037868 elfA gene Proteins 0.000 claims description 3
- 101150043262 elfC gene Proteins 0.000 claims description 3
- 101150105675 elfD gene Proteins 0.000 claims description 3
- 101150054317 elfG gene Proteins 0.000 claims description 3
- 101150043770 fimA gene Proteins 0.000 claims description 3
- 101150030956 fimC gene Proteins 0.000 claims description 3
- 101150093898 fimD gene Proteins 0.000 claims description 3
- 101150028805 fimF gene Proteins 0.000 claims description 3
- 101150015947 fimH gene Proteins 0.000 claims description 3
- 101150081842 fimI gene Proteins 0.000 claims description 3
- 101150014100 pilA gene Proteins 0.000 claims description 3
- 101150067007 sfmA gene Proteins 0.000 claims description 3
- 101150028527 sfmD gene Proteins 0.000 claims description 3
- 101150092333 ycbU gene Proteins 0.000 claims description 3
- 101150118384 ydeQ gene Proteins 0.000 claims description 3
- 101150113263 ydeS gene Proteins 0.000 claims description 3
- 101150032291 yhcA gene Proteins 0.000 claims description 3
- 101150113907 yhcD gene Proteins 0.000 claims description 3
- 101150057359 yhcE gene Proteins 0.000 claims description 3
- 101150104283 yhcF gene Proteins 0.000 claims description 3
- 101100270984 Bacillus subtilis (strain 168) aseR gene Proteins 0.000 claims description 2
- 230000007812 deficiency Effects 0.000 claims description 2
- 101150049073 ydeT gene Proteins 0.000 claims description 2
- 101150023306 yraH gene Proteins 0.000 claims description 2
- 101100052706 Escherichia coli (strain K12) yfcU gene Proteins 0.000 claims 2
- 101100451793 Escherichia coli (strain K12) htrE gene Proteins 0.000 claims 1
- 101100319858 Escherichia coli (strain K12) yadC gene Proteins 0.000 claims 1
- 101100487670 Escherichia coli (strain K12) yadK gene Proteins 0.000 claims 1
- 101100487671 Escherichia coli (strain K12) yadL gene Proteins 0.000 claims 1
- 101100487672 Escherichia coli (strain K12) yadM gene Proteins 0.000 claims 1
- 101100487673 Escherichia coli (strain K12) yadN gene Proteins 0.000 claims 1
- 101100487678 Escherichia coli (strain K12) yadV gene Proteins 0.000 claims 1
- 101100105583 Escherichia coli (strain K12) ybgD gene Proteins 0.000 claims 1
- 101100105589 Escherichia coli (strain K12) ybgO gene Proteins 0.000 claims 1
- 101100052299 Escherichia coli (strain K12) ybgP gene Proteins 0.000 claims 1
- 101100052300 Escherichia coli (strain K12) ybgQ gene Proteins 0.000 claims 1
- 101100488198 Escherichia coli (strain K12) yehA gene Proteins 0.000 claims 1
- 101100488199 Escherichia coli (strain K12) yehB gene Proteins 0.000 claims 1
- 101100488200 Escherichia coli (strain K12) yehC gene Proteins 0.000 claims 1
- 101100488201 Escherichia coli (strain K12) yehD gene Proteins 0.000 claims 1
- 101100052701 Escherichia coli (strain K12) yfcO gene Proteins 0.000 claims 1
- 101100052702 Escherichia coli (strain K12) yfcP gene Proteins 0.000 claims 1
- 101100052703 Escherichia coli (strain K12) yfcQ gene Proteins 0.000 claims 1
- 101100052704 Escherichia coli (strain K12) yfcR gene Proteins 0.000 claims 1
- 101100052705 Escherichia coli (strain K12) yfcS gene Proteins 0.000 claims 1
- 101100052707 Escherichia coli (strain K12) yfcV gene Proteins 0.000 claims 1
- 101100267132 Escherichia coli (strain K12) ygiL gene Proteins 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- 101150094333 yqiG gene Proteins 0.000 claims 1
- 101150035644 yqiH gene Proteins 0.000 claims 1
- 101150092370 yqiI gene Proteins 0.000 claims 1
- 101150088530 yraI gene Proteins 0.000 claims 1
- 101150016952 yraJ gene Proteins 0.000 claims 1
- 101150075514 yraK gene Proteins 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 38
- 239000002609 medium Substances 0.000 description 36
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 description 36
- 229920000903 polyhydroxyalkanoate Polymers 0.000 description 36
- 229920000070 poly-3-hydroxybutyrate Polymers 0.000 description 35
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 20
- 230000032050 esterification Effects 0.000 description 9
- 238000005886 esterification reaction Methods 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 7
- 230000010261 cell growth Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 101150063051 hom gene Proteins 0.000 description 5
- 239000002054 inoculum Substances 0.000 description 5
- 230000003834 intracellular effect Effects 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 101150014006 thrA gene Proteins 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 4
- 108091033409 CRISPR Proteins 0.000 description 4
- 238000010356 CRISPR-Cas9 genome editing Methods 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 238000011218 seed culture Methods 0.000 description 4
- 239000000872 buffer Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000004817 gas chromatography Methods 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 101150094644 rhtC gene Proteins 0.000 description 3
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 102000018120 Recombinases Human genes 0.000 description 2
- 108010091086 Recombinases Proteins 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 229940100228 acetyl coenzyme a Drugs 0.000 description 2
- 238000003149 assay kit Methods 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 235000010216 calcium carbonate Nutrition 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000001493 electron microscopy Methods 0.000 description 2
- 239000003517 fume Substances 0.000 description 2
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 2
- 235000003642 hunger Nutrition 0.000 description 2
- 210000003000 inclusion body Anatomy 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 description 2
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- CDUFCUKTJFSWPL-UHFFFAOYSA-L manganese(II) sulfate tetrahydrate Chemical compound O.O.O.O.[Mn+2].[O-]S([O-])(=O)=O CDUFCUKTJFSWPL-UHFFFAOYSA-L 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 230000037353 metabolic pathway Effects 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 2
- 229960000268 spectinomycin Drugs 0.000 description 2
- 230000037351 starvation Effects 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 101150066838 12 gene Proteins 0.000 description 1
- 231100000582 ATP assay Toxicity 0.000 description 1
- 238000010354 CRISPR gene editing Methods 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 108700005078 Synthetic Genes Proteins 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229920000704 biodegradable plastic Polymers 0.000 description 1
- 230000032770 biofilm formation Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 230000035605 chemotaxis Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000005350 fused silica glass Substances 0.000 description 1
- 108091008053 gene clusters Proteins 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229940054441 o-phthalaldehyde Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- ALZOLUNSQWINIR-UHFFFAOYSA-N quinmerac Chemical compound OC(=O)C1=C(Cl)C=CC2=CC(C)=CN=C21 ALZOLUNSQWINIR-UHFFFAOYSA-N 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- QEVHRUUCFGRFIF-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C(C5=CC=C(OC)C=C5N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 QEVHRUUCFGRFIF-MDEJGZGSSA-N 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000037352 starvation stress Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000011222 transcriptome analysis Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/08—Lysine; Diaminopimelic acid; Threonine; Valine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/185—Escherichia
- C12R2001/19—Escherichia coli
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110053059.7 | 2021-01-15 | ||
CN202110053059.7A CN112680393B (zh) | 2021-01-15 | 2021-01-15 | 一种能提高生产效率的无菌毛大肠杆菌的构建及应用 |
PCT/CN2021/108590 WO2022151700A1 (zh) | 2021-01-15 | 2021-07-27 | 一种能提高生产效率的无菌毛大肠杆菌的构建及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2023535865A JP2023535865A (ja) | 2023-08-22 |
JP7507897B2 true JP7507897B2 (ja) | 2024-06-28 |
Family
ID=75458044
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022575251A Active JP7507897B2 (ja) | 2021-01-15 | 2021-07-27 | 生産効率を向上させる線毛無し大腸菌の構築及び使用 |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP7507897B2 (zh) |
CN (1) | CN112680393B (zh) |
WO (1) | WO2022151700A1 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109576198B (zh) * | 2018-11-09 | 2022-06-07 | 南京工业大学 | 一株敲除fimA基因的重组大肠杆菌及其构建方法与应用 |
CN112680393B (zh) * | 2021-01-15 | 2023-04-07 | 江南大学 | 一种能提高生产效率的无菌毛大肠杆菌的构建及应用 |
CN113106049A (zh) * | 2021-04-26 | 2021-07-13 | 江南大学 | 一种不合成肠杆菌共同抗原和鞭毛的基因工程菌及其应用 |
CN113174393B (zh) * | 2021-04-28 | 2023-09-12 | 江南大学 | 一种改善大肠杆菌耐药性的方法及其应用 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101392231A (zh) | 2008-08-22 | 2009-03-25 | 山东大学 | 一种重组大肠杆菌及应用其以生物质原料生产phb的方法 |
CN102212501A (zh) | 2011-03-31 | 2011-10-12 | 山东大学 | 一种重组大肠杆菌及应用其以单一碳源生产phbv的方法 |
CN104862329A (zh) | 2015-04-23 | 2015-08-26 | 上海工业生物技术研发中心 | L-苏氨酸基因工程生产菌 |
CN109576198A (zh) | 2018-11-09 | 2019-04-05 | 南京工业大学 | 一株敲除fimA基因的重组大肠杆菌及其构建方法与应用 |
CN109852572A (zh) | 2019-01-28 | 2019-06-07 | 江南大学 | 一种敲除大肠杆菌pts系统提高l-苏氨酸产量的方法 |
CN110055205A (zh) | 2019-05-13 | 2019-07-26 | 南京工业大学 | 一种敲除fimH基因的重组大肠杆菌及其构建方法与应用 |
CN110669709A (zh) | 2019-07-31 | 2020-01-10 | 江南大学 | 一种通过敲除鞭毛和菌毛基因高效合成phb的方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6989265B2 (en) * | 2002-01-23 | 2006-01-24 | Wisconsin Alumni Research Foundation | Bacteria with reduced genome |
WO2016165025A1 (en) * | 2015-04-16 | 2016-10-20 | National Research Council Of Canada | Genetically engineered c1-utilizing microorganisms and processes for their production and use |
CN112680393B (zh) * | 2021-01-15 | 2023-04-07 | 江南大学 | 一种能提高生产效率的无菌毛大肠杆菌的构建及应用 |
-
2021
- 2021-01-15 CN CN202110053059.7A patent/CN112680393B/zh active Active
- 2021-07-27 WO PCT/CN2021/108590 patent/WO2022151700A1/zh active Application Filing
- 2021-07-27 JP JP2022575251A patent/JP7507897B2/ja active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101392231A (zh) | 2008-08-22 | 2009-03-25 | 山东大学 | 一种重组大肠杆菌及应用其以生物质原料生产phb的方法 |
CN102212501A (zh) | 2011-03-31 | 2011-10-12 | 山东大学 | 一种重组大肠杆菌及应用其以单一碳源生产phbv的方法 |
CN104862329A (zh) | 2015-04-23 | 2015-08-26 | 上海工业生物技术研发中心 | L-苏氨酸基因工程生产菌 |
CN109576198A (zh) | 2018-11-09 | 2019-04-05 | 南京工业大学 | 一株敲除fimA基因的重组大肠杆菌及其构建方法与应用 |
CN109852572A (zh) | 2019-01-28 | 2019-06-07 | 江南大学 | 一种敲除大肠杆菌pts系统提高l-苏氨酸产量的方法 |
CN110055205A (zh) | 2019-05-13 | 2019-07-26 | 南京工业大学 | 一种敲除fimH基因的重组大肠杆菌及其构建方法与应用 |
CN110669709A (zh) | 2019-07-31 | 2020-01-10 | 江南大学 | 一种通过敲除鞭毛和菌毛基因高效合成phb的方法 |
Also Published As
Publication number | Publication date |
---|---|
JP2023535865A (ja) | 2023-08-22 |
CN112680393B (zh) | 2023-04-07 |
CN112680393A (zh) | 2021-04-20 |
WO2022151700A1 (zh) | 2022-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7507897B2 (ja) | 生産効率を向上させる線毛無し大腸菌の構築及び使用 | |
CN109810991B (zh) | 二氢蝶酸合酶基因folP的用途 | |
BRPI1008267B1 (pt) | Processo para a produção fermentativa de ácido succínico | |
CN110387347B (zh) | 一株大肠杆菌膜壁精简底盘菌株及其高产phb的应用 | |
CN110669709B (zh) | 一种通过敲除鞭毛和菌毛基因高效合成phb的方法 | |
CN114381415B (zh) | 高产pha的基因重组菌及其构建方法 | |
CN111235169A (zh) | 一种GTP环化水解酶I基因folE及应用 | |
CN105821071A (zh) | 一种基于同源重组的乳酸片球菌dq2的无标记基因敲除方法 | |
CN110373436A (zh) | 一种产双高-γ-亚麻酸卷枝毛霉细胞工厂的构建方法及发酵技术 | |
Liu et al. | Construction of a robust Sphingomonas sp. strain for welan gum production via the expression of global transcriptional regulator IrrE | |
CN111996155B (zh) | 一种提高l-组氨酸产生菌生产能力的方法 | |
WO2018199546A1 (ko) | 신규한 피루브산 전달효소 | |
CN106635945B (zh) | 重组菌株及其制备方法和生产l-苏氨酸的方法 | |
CN113106049A (zh) | 一种不合成肠杆菌共同抗原和鞭毛的基因工程菌及其应用 | |
CN113583931B (zh) | 魏氏柠檬酸杆菌ansB基因敲除突变株及其应用 | |
CN109097374A (zh) | 一种铜绿假单胞菌工程菌株的制备方法、菌株及其应用 | |
KR102157781B1 (ko) | 디카르복시산 생산을 위한 미생물 및 이를 이용한 디카르복시산 생산방법 | |
CN110373372B (zh) | 一种通过敲除lps合成基因簇高效合成phb的方法 | |
CN112575041B (zh) | 一种混合碳源高效发酵生产phb的工程菌及其应用 | |
WO2018056794A1 (ko) | 아세트산을 유일 탄소원으로 이용할 수 있는 미생물 | |
CN111334445B (zh) | 长链二元酸生产菌株及其制备方法和应用 | |
KR101495640B1 (ko) | 신규한 렙토린비아 코리엔시스 kiost-1 균주 및 이를 이용한 바이오매스 생산 방법 | |
CN116478893B (zh) | 一种产丙酸的工程益生菌的构建与应用 | |
CN108690849A (zh) | 一种提高头孢菌素c酰化酶活性的方法 | |
CN112852696B (zh) | 一株高产甘露醇的肠膜明串珠菌突变菌株及其应用方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230202 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231219 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240319 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240521 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240618 |